Listings

$4 Million Revenue, Prominent Regenerative Medicine Clinic based in Southern California

California
$10,000,000
$4,000,000
CAMED1C

American HealthCare Capital is pleased to introduce a highly successful regenerative medicine clinic for sale in Southern California. The company provides non-surgical pain management for a multitude of degenerative Musculoskeletal Disorders and sports related injuries. They currently operate in Southern California, but the platform is scalable nationwide. Offices can be functional and profitable as turnkey operations in hundreds of clinics around the country are using their in-house, proprietary, internet and radio marketing campaigns. The clinic offers Stem Cell Therapy, Platelet Rick Plasma (PRP) Therapy, which fall under the term “regenerative medicine” or “biomedicine.” These procedures are designed to stimulate the immune system to heal and rebuild damaged joints and tissue without the significant risks that accompany surgery, joint replacement, or other invasive procedures.

The clinic also offers cosmetic procedures, including Vampire Face Lifts, Botox, and facial fillers. Although this profit center is small at this time, it could easily outperform the musculoskeletal area with low-cost mid-level practitioner delivery instead of using an MD. Vampire Face Lifts are an alternative to surgery, using the same platelets from the blood and stem cells from bone marrow used in the orthopedic branch of the company, and made famous by the Kardashians. All of which allow additional growth opportunities for future ownership.

The company’s payer mix is 100% Private Pay. Gross revenues have been in the $3.3 million to $3.6 million range over the past couple of years. COVID-19 caused a slight decrease in 2020 revenues, but business has since picked up. They are projecting $4 Million in annual gross revenue in 2021 with 50% in pretax profits. Bloomberg News foresees stem cell therapy as potential multibillion dollar industry in the near future for the treatment of pain and other related degenerative diseases. Once the insurance industry approves a reimbursement schedule for stem cell treatment, it will become one of the top revenue generators in the healthcare system for doctors.

The full complement of staff is expected to stay on under new ownership. The owner, who also serves as medical director, is flexible and would be willing to sell to a strategic or equity partner, either all or part of the company, with the intent to grow the platform from a regional business to a national organization.

The asking price for this opportunity is $10 million.



If you would like to learn more, please use the link on the right-hand side of the page to execute our NDA. You will need to copy the Listing Code (Example: TXMC1A) and Listing Title (Example: $1 Million Home Health Agency in Texas) from the summary above to complete the NDA.